137 related articles for article (PubMed ID: 38430023)
1. Mitochondria-targeted reactive oxygen species blockor SS-31 blocks hepatic stellate cell activation and alleviates hepatic fibrosis by regulating NLRP3 inflammasomes.
Liu L; Wei Y; Xie N; Cai H; Lin Y
Cell Mol Biol (Noisy-le-grand); 2024 Feb; 70(2):183-188. PubMed ID: 38430023
[TBL] [Abstract][Full Text] [Related]
2. NLR Family Pyrin Domain-Containing 3 Inflammasome Activation in Hepatic Stellate Cells Induces Liver Fibrosis in Mice.
Inzaugarat ME; Johnson CD; Holtmann TM; McGeough MD; Trautwein C; Papouchado BG; Schwabe R; Hoffman HM; Wree A; Feldstein AE
Hepatology; 2019 Feb; 69(2):845-859. PubMed ID: 30180270
[TBL] [Abstract][Full Text] [Related]
3. Saikosaponin d Alleviates Liver Fibrosis by Negatively Regulating the ROS/NLRP3 Inflammasome Through Activating the ERβ Pathway.
Zhang K; Lin L; Zhu Y; Zhang N; Zhou M; Li Y
Front Pharmacol; 2022; 13():894981. PubMed ID: 35694250
[No Abstract] [Full Text] [Related]
4. p66Shc Contributes to Liver Fibrosis through the Regulation of Mitochondrial Reactive Oxygen Species.
Zhao Y; Wang Z; Feng D; Zhao H; Lin M; Hu Y; Zhang N; Lv L; Gao Z; Zhai X; Tian X; Yao J
Theranostics; 2019; 9(5):1510-1522. PubMed ID: 30867846
[No Abstract] [Full Text] [Related]
5. Potentiation of hepatic stellate cell activation by extracellular ATP is dependent on P2X7R-mediated NLRP3 inflammasome activation.
Jiang S; Zhang Y; Zheng JH; Li X; Yao YL; Wu YL; Song SZ; Sun P; Nan JX; Lian LH
Pharmacol Res; 2017 Mar; 117():82-93. PubMed ID: 27940204
[TBL] [Abstract][Full Text] [Related]
6. Aucubin ameliorates liver fibrosis and hepatic stellate cells activation in diabetic mice via inhibiting ER stress-mediated IRE1α/TXNIP/NLRP3 inflammasome through NOX4/ROS pathway.
Bao X; Li J; Ren C; Wei J; Lu X; Wang X; Du W; Jin X; Ma B; Zhang Q; Ma B
Chem Biol Interact; 2022 Sep; 365():110074. PubMed ID: 35961541
[TBL] [Abstract][Full Text] [Related]
7. Saikosaponin-d protects against liver fibrosis by regulating the estrogen receptor-β/NLRP3 inflammasome pathway.
Lin L; Zhou M; Que R; Chen Y; Liu X; Zhang K; Shi Z; Li Y
Biochem Cell Biol; 2021 Oct; 99(5):666-674. PubMed ID: 33974808
[TBL] [Abstract][Full Text] [Related]
8. Double-Negative T Cells Regulate Hepatic Stellate Cell Activation to Promote Liver Fibrosis Progression
Yang Y; Sheng Y; Wang J; Zhou X; Li W; Zhang C; Guo L; Han C
Front Immunol; 2022; 13():857116. PubMed ID: 35371052
[TBL] [Abstract][Full Text] [Related]
9. Pelargonidin ameliorates CCl
Shi YS; Li XX; Li HT; Zhang Y
Food Funct; 2020 Jun; 11(6):5156-5165. PubMed ID: 32432601
[TBL] [Abstract][Full Text] [Related]
10. Role of aldosterone in the activation of primary mice hepatic stellate cell and liver fibrosis via NLRP3 inflammasome.
Li Y; Zhang Y; Chen T; Huang Y; Zhang Y; Geng S; Li X
J Gastroenterol Hepatol; 2020 Jun; 35(6):1069-1077. PubMed ID: 31860730
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-(1-7) Improves Liver Fibrosis by Regulating the NLRP3 Inflammasome via Redox Balance Modulation.
Cai SM; Yang RQ; Li Y; Ning ZW; Zhang LL; Zhou GS; Luo W; Li DH; Chen Y; Pan MX; Li X
Antioxid Redox Signal; 2016 May; 24(14):795-812. PubMed ID: 26728324
[TBL] [Abstract][Full Text] [Related]
12. The anti-liver fibrosis effect of Tibetan medicine (Qiwei Tiexie capsule) is related to the inhibition of NLRP3 inflammasome activation in vivo and in vitro.
Wang S; Ye F; Ren Q; Sun S; Xia W; Wang Z; Guo H; Li H; Zhang S; Lowe S; Chen M; Du Q; Weihong Li
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117283. PubMed ID: 37827298
[TBL] [Abstract][Full Text] [Related]
13. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
14. Regulation of SIRT1-TLR2/TLR4 pathway in cell communication from macrophages to hepatic stellate cells contribute to alleviates hepatic fibrosis by Luteoloside.
Xiu M; Zhao Y; Wang X; Yuan S; Qin B; Sun J; Cui L; Song J
Acta Histochem; 2023 Jan; 125(1):151989. PubMed ID: 36529079
[TBL] [Abstract][Full Text] [Related]
15. Axitinib attenuates the progression of liver fibrosis by restoring mitochondrial function.
Li H; Zhang R; Hu Y; Li J; Yang Y; Wu D; Gu X; Zhang F; Zhou H; Yang C
Int Immunopharmacol; 2023 Sep; 122():110555. PubMed ID: 37399607
[TBL] [Abstract][Full Text] [Related]
16. [Adeno-associated virus-mediated hepatocyte-specific NDUFA13 overexpression protects against CCl
Xu X; Feng J; Luo Y; He X; Zang J; Huang D
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Feb; 44(2):201-209. PubMed ID: 38501404
[TBL] [Abstract][Full Text] [Related]
17. Ganoderma lucidum polysaccharide inhibits HSC activation and liver fibrosis via targeting inflammation, apoptosis, cell cycle, and ECM-receptor interaction mediated by TGF-β/Smad signaling.
Chen C; Chen J; Wang Y; Fang L; Guo C; Sang T; Peng H; Zhao Q; Chen S; Lin X; Wang X
Phytomedicine; 2023 Feb; 110():154626. PubMed ID: 36603342
[TBL] [Abstract][Full Text] [Related]
18. Jaceosidin attenuates the progression of hepatic fibrosis by inhibiting the VGLL3/HMGB1/TLR4 signaling pathway.
Yao Y; Zuo X; Shao F; Yu K; Liang Q
Phytomedicine; 2024 Jun; 128():155502. PubMed ID: 38489889
[TBL] [Abstract][Full Text] [Related]
19. Hepatoprotective effect of Baicalin against thioacetamide-induced cirrhosis in rats: Targeting NOX4/NF-κB/NLRP3 inflammasome signaling pathways.
Zaghloul RA; Zaghloul AM; El-Kashef DH
Life Sci; 2022 Apr; 295():120410. PubMed ID: 35182557
[TBL] [Abstract][Full Text] [Related]
20. Ginsenoside Rg1 attenuates lipopolysaccharide-induced chronic liver damage by activating Nrf2 signaling and inhibiting inflammasomes in hepatic cells.
Zhou H; Liu Y; Su Y; Ji P; Kong L; Sun R; Zhang D; Xu H; Li W; Li W
J Ethnopharmacol; 2024 Apr; 324():117794. PubMed ID: 38244950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
